COPD

A patient with lung adenocarcinoma who was treated with an immune checkpoint inhibitor developed symptoms related to asthma and breathing obstruction.

The study authors said that, to their knowledge, this will be the first systematic review focusing on the effects of cognitive interventions for those with chronic respiratory diseases.

The treatment improved lung function at 12 weeks and quality of life at 4 weeks.

But analysis does suggest a small increase in risk for individuals who used cigarettes and electronic nicotine delivery systems together.

Data show that dose-response relationships and long-term safety of ICS in people with chronic obstructive pulmonary disease are unclear and require further investigation.

Regeneron and Sanofi’s Dupilumab is the first biologic to demonstrate a clinically meaningful and statistically significant reduction in exacerbations compared with the placebo.

Study findings confirmed that in asthma, chronic obstructive pulmonary disease, HIV, and influenza, census data differed from the epidemiological data.

Variety of interventions improves morbidity, mortality, associated costs for patients with chronic obstructive pulmonary disorder.

The National Institute of Health’s grant funds a phase 2 clinical trial of doxycycline in a large group of individuals with the 2 conditions who are smokers or used to smoke.

Pivotal resource helps health care professionals diagnose, manage, and prevent this group of lung diseases.

Covis announced positive topline results for 2 new medications that can treat patients with moderate to severe stable chronic obstructive pulmonary disease.

A short 5-minute educational video may improve health care professionals’ knowledge about the herpes zoster vaccine, guidelines, and what patients should receive it.

People have been taking probiotics to support digestive health for centuries, but researchers in the pulmonary field have turned their attention toward how microbiome science can be used to support the lungs.

Breztri is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease.

The value of a patient-first approach and telehealth for addressing the complex health care coordination needs of patients with rare pulmonary diseases has never been more critical than during the COVID-19 pandemic.

Agency hopes green light for complex drug device combination improves competition and access more affordable medications.

Wixela Inhub is indicated for the treatment of asthma in patients 4 years of age and older and maintenance treatment of patients with chronic obstructive pulmonary disease.

Breo Ellipta is indicated for long-term, once-daily, maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.

Advair Diskus is indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease.

Bevespi is indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease.

Pharmacists have the potential to make a positive impact by screening patients, providing counseling, encouraging beneficial interventions, and helping tailor patient regimens based on personalized needs.

Study shows the benefit of green and blue spaces for individuals with COPD living in urban communities.

Inspiratory muscle training was originally devised to be used by athletes and individuals with breathing problems such as chronic obstructive pulmonary disease, asthma, and bronchitis.

Ten quiz questions to assess your knowledge on common treatments for chronic obstructive pulmonary disease.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.